Oxycodone is a potent pain medication and a nervous system depressant sold under the trade names OxyContin, Percodan, and Percocet, among others
Olympus has developed applications for the new DRI Oxycodone assay on its chemistry-immuno analysers, in conjunction with the assay's recent introduction by Microgenics.
The assay has applications for the entire Olympus AU chemistry-immuno analyser system platform, including the AU400/400e, AU600, AU640/640e, AU2700 and AU5400 chemistry-immuno analysers.
The Oxycodone assay is NAD-G6PDH based, and can be read bichromatically at 340/410nm.
Results can be determined as qualitative (pass/fail) at cutoffs of 100ng/ml or 300ng/ml.
They can also be determined semi-quantitatively up to 1000ng/ml.
The DRI Oxycodone Assay is used to measure Oxycodone in urine.
Olympus Diagnostic Systems provides products to meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks and pharmaceutical labs.
Olympus claims to offer the broadest standardised line of random access chemistry-immuno analysers, along with lab automation systems, comprehensive patient safety systems, blood bank analysers and reagents.
The company says these save laboratories time, enhance patient safety, maximise productivity, and deliver fast, reliable results.
